[Antibiotic management of presumptive bacterial meningitis in adults (rational, methods, course, and follow-up)]

Area of Science:

• Infectious Diseases
• Bacteriology
• Clinical Pharmacology

Background:

• Community-acquired meningitis incidence in adults is 0.6-4 per 100,000.
• Key bacterial pathogens include Streptococcus pneumoniae, Neisseria meningitidis, and Listeria monocytogenes.
• Increasing antibiotic resistance, particularly in S. pneumoniae, poses a therapeutic challenge.

Purpose of the Study:

• To review the current understanding of community-acquired meningitis in adults.
• To highlight the impact of antibiotic resistance on treatment efficacy.
• To address the limitations of current therapeutic guidelines.

Main Methods:

• Literature review of epidemiological data on meningitis incidence.
• Analysis of common bacterial causative agents and their resistance patterns.
• Evaluation of existing treatment strategies and their clinical basis.

Main Results:

• Third-generation cephalosporins show potential clinical failure in treating S. pneumoniae meningitis.
• Antibiotic resistance in S. pneumoniae is a significant factor contributing to treatment outcomes.
• Current therapeutic recommendations often rely on experimental models rather than robust clinical trials.

Conclusions:

• Effective treatment of bacterial meningitis requires addressing antibiotic resistance.
• Further clinical trials are crucial for developing evidence-based therapeutic guidelines.
• Improved management strategies are needed for S. pneumoniae meningitis in adults.